spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Bio-Rad Launches EconoFit Chromatography Column Packs

Bio-Rad

Wide Selection of Resins in New, Convenient Column Format to Support the Development of Protein Purification Workflows


HERCULES, California, June 28, 2022:
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of EconoFit Low-Pressure Prepacked Chromatography Column Packs to support resin screening experiments in the development of protein purification workflows.

Bio-Rad’s range of EconoFit Columns provides a wide selection of resins in a prepacked format, allowing customers to simply screen resins and select the optimal chemistry for different target molecules. The new packs include mixed-mode, cation, and anion exchange resin columns, as well as a pack designed for His-tag protein purification. The convenient, easy-to-use and disposable column format is fully compatible with Bio-Rad’s NGC Chromatography Systems and other commonly used chromatography systems. Columns are available in 1 ml and 5 ml sizes.

“Similar resins can give different results for different target molecules, and with Bio-Rad’s EconoFit Column Packs our customers can easily perform resin scouting to identify the one which yields the best outcome for their chromatography application,” said Ertan Ozyamak, PhD, Bio-Rad Global Product Manager for lab-scale chromatography products. “Our columns deliver run-to-run uniformity to support preparative scale purifications and/or method development for new target proteins, as well as to improve existing workflows.”
phone +1-510-724-7000
email UK_orders@bio-rad.com
web www.bio-rad.com
email 1000 Alfred Nobel Drive Hercules, California 94547
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Evonetix Commences Early Access Program for DNA Synthesised by Thermal Control on its Semiconductor Chip

Cambridge, UK 16th August 2022 – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the opening of its early access program for semiconductor synthesised DNA. Evonetix’s DNA synthesis capability brings together patented semiconductor chip design and proprietary, thermally controlled synthesis chemistry, which will be integral to the Company’s future gene synthesis platforms.
More info >>


White Papers

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement